| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020405 |
| Receipt No. | R000023565 |
| Scientific Title | The influences of active and passive activation on cerebral blood flow and motor performances during finger motions |
| Date of disclosure of the study information | 2016/01/05 |
| Last modified on | 2019/07/30 (Ver. 6) |
| Basic information | ||
| Public title | The influences of active and passive activation on cerebral blood flow and motor performances during finger motions | |
| Acronym | The influences of active and passive activation on cerebral blood flow and motor performances during finger motions | |
| Scientific Title | The influences of active and passive activation on cerebral blood flow and motor performances during finger motions | |
| Scientific Title:Acronym | The influences of active and passive activation on cerebral blood flow and motor performances during finger motions | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To consider impact of active and passive brain activation on cerebral blood flow and finger exercise performance
|
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Concentration of oxyhemoglobin during motor task |
| Key secondary outcomes | Motor peformances(the number of motor task, the successful number of motor task, error ration of motor task, smoothness of hand during motor task) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Visit1:Motor task, Control(rest;2 minutes), Motor task
interval(at least a day) Visit2: Motor task, Simple hand grasping exercise(2 minutes), Motor task interval(at least a day) Visit3: Motor task, Transcranial direct current stimulation(15 minutes), Motor task |
|
| Interventions/Control_2 | Visit1: Motor task, Control(rest;2 minutes), Motor task
interval(at least a day) Visit2: Motor task, Transcranial direct current stimulation(15 minutes), Motor task interval(at least five days) Visit3: Motor task, Simple hand grasping exercise(2 minutes), Motor task |
|
| Interventions/Control_3 | Visit1: Motor task, Simple hand grasping exercise(2 minutes), Motor task
interval (at least a day) Visit2: Motor task, Control(rest;2 minutes), Motor task interval (at least a day) Visit3:Motor task, Transcranial direct current stimulation(15 minutes), Motor task |
|
| Interventions/Control_4 | Visit1: Motor task, Simple hand grasping exercise(2 minutes), Motor task
interval (at least a day) Visit2: Motor task, Transcranial direct current stimulation(15 minutes), Motor task interval (at least five days) Visit3: Motor task, Control(rest;2 minutes), Motor task |
|
| Interventions/Control_5 | Visit1: Motor task, Transcranial direct current stimulation(15 minutes), Motor task
interval (at least five days) Visit2: Motor task, Control(rest;2 minutes), Motor task interval (at least a day) Visit3: Motor task, Simple hand grasping exercise(2 minutes), Motor task |
|
| Interventions/Control_6 | Visit1: Motor task, Transcranial direct current stimulation(15 minutes), Motor task
interval (at least five days) Visit2: Motor task, Simple hand grasping exercise(2 minutes), Motor task interval (at least a day) Visit3: Motor task, Control(rest;2 minutes), Motor task |
|
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The dominant hand is right-handed.
Who consent is obtained in writing with respect to the participation of research. |
|||
| Key exclusion criteria | There is a history of neurological disorders, psychiatric disorders.
There is a history or current medical history of impaired cognitive function. There is musculoskeletal disorders of the hand finger. |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hiroshima University Graduate School of Biomedical & Health Sciences | ||||||
| Division name | Analysis & Control of Upper Extremity Function | ||||||
| Zip code | |||||||
| Address | 1-2-3 Kasumi Hiroshima Japan | ||||||
| TEL | 082-257-5455 | ||||||
| torusuna@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hiroshima University Graduate School of Biomedical & Health Sciences | ||||||
| Division name | Analysis & Control of Upper Extremity Function | ||||||
| Zip code | |||||||
| Address | 1-2-3 Kasumi Hiroshima Japan | ||||||
| TEL | 082-257-5457 | ||||||
| Homepage URL | |||||||
| m145422@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Hiroshima University Graduate School of Biomedical & Health Sciences, Control of Upper Extremity Function |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants in aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023565 |